Exercise Induced Non-Sustained Ventricular Tachycardia and Indication for Invasive Management

Diagnostic stress echo testing is commonly performed in patients with known or suspected cardiovascular disease. There has been considerable debate in management of exercise induced non-sustained ventricular tachycardia (NSVT). In this case report, we present our experience with a case of exercise induced NSVT, and subsequent angiographically significant left anterior descending (LAD) coronary artery lesion

Chronic Ethanol Intake Promotes Double Gluthatione S-transferase/transforming Growth Factor-α-positive Hepatocellular Lesions In Male Wistar Rats

The chronic ethanol intake influence on the gluthatione S-transferase (GST-P) and transforming growth factor α (TGF-α) expression in remodeling/persistent preneoplastic lesions (PNLs) was evaluated in the resistant hepatocyte model. Male Wistar rats were allocated into five groups: G1, non-treated, fed water and chow ad libitum; G2, non-treated and pair-fed chow (restricted to match that of G3 group) and a maltodextrin (MD) solution in tap water (matched ethanol-derived calories); G3, fed 5% ethanol in drinking water and chow ad libitum; G4, diethylnitrosamine (DEN, 200 mg/kg, body weight) plus 200 parts per million of 2-acetylaminofluorene (2-AAF) for 3 weeks and pair-fed chow (restricted to match that of G5 group) and an MD solution in tap water (matched ethanol-derived calories); G5, DEN/2-AAF treatment, fed ethanol 5% and chow ad libitum. All animals were subjected to 70% partial hepatectomy at week 3 and sacrificed at weeks 12 or 22, respectively. Liver samples were collected for histological analysis or immunohistochemical expression of GST-P, TGF-α and proliferating cell nuclear antigen or zymography for matrix metalloproteinases-2 and-9. At the end of ethanol treatment, there was a significant increase in the percentage of liver area occupied by persistent GST-P-positive PNLs, the number of TGF-α-positive PNLs and the development of liver tumors in ethanol-fed and DEN/2-AAF-treated groups (G5 versus G4, P < 0.001). In addition, ethanol feeding led to a significant increase in cell proliferation mainly in remodeling and persistent PNLs with immunoreactivity for TGF-α at week 22 (P < 0.001). Gelatinase activities were not altered by ethanol treatment. The results demonstrated that ethanol enhances the selective growth of PNL with double expression of TGF-α and GST-P markers. © 2008 Japanese Cancer Association.992221228Pöschl, G., Seitz, H.K., Alcohol and cancer (2004) Alcohol Alcohol, 39, pp. 155-165Bofetta, P., Hashibe, M., Alcohol and cancer (2006) Lancet Oncol, 7, pp. 149-156Brown, L.M., Epidemiology of alcohol-associated cancers (2005) Alcohol, 35, pp. 161-168Voight, M.D., Alcohol in hepatocellular cancer (2005) Clin Liver Dis, 9, pp. 151-169Vidal, F., Toda, R., Gutiérrez, C., Influence of chronic alcohol abuse and liver disease on hepatic aldehyde dehydrogenase activity (1998) Alcohol, 15, pp. 3-8Lieber, C.S., Abittan, C.S., Pharmacology and metabolism of alcohol, including its metabolics effects and interactions with other drugs (1999) Clin Dermatol, 17, pp. 365-379Bunout, D., Nutritional and metabolic effects of alcoholism: Their relationship with alcoholic liver disease (1999) Nutrition, 15, pp. 583-589Niemellä, O., Distribution of ethanol-induced protein adducts in vivo: Relationship to tissue injury (2001) Free Rad Biol Med, 31, pp. 1533-1538Brooks, T.J., Theruvathu, J.A., DNA adducts from acetaldehyde: Implications for alcohol-related carcinogenesis (2005) Alcohol, 35, pp. 187-193Verna, L., Whysner, J., Williams, G.M., N-Nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-Adduct formation, mutagenicity and tumor initiation (1996) Pharmacol Ther, 71, pp. 57-81Friedman, S.L., Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implication (2004) Nat Clin Pract Gastroenterol Hepatol, 1, pp. 98-105Purohit, V., Brenner, D.A., Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman symposium (2006) Hepatology, 43, pp. 872-878Arthur, M.J.P., Fibrogenesis: Metalloproteinases and their inhibitors in liver fibrosis (2000) Am J Physiol Gastrointest Liver Phisiol, 279, pp. 245-249Tatsuta, M., Iishi, H., Baba, M., Enhancement by ethyl alcohol experimental hepatocarcinogenesis induced by N-nitrosomorpholine (1997) Int J Cancer, 71, pp. 1045-1048Karim, M.R., Wanibuchi, H., Wei, M., Morimura, K., Salim, E., Fukushima, S., Enhancing risk of ethanol on MeIQx-induced rat hepatocarcinogenesis is accompanied with increased levels of cellular proliferation and oxidative stress (2003) Cancer Lett, 192, pp. 37-47Kushida, M., Wanibuchi, H., Morimura, K., Dose-dependence of promotion of 2-amino-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol: Evidence for a threshold (2005) Cancer Sci, 96, pp. 747-757Stickel, F., Schuppan, D., Hahn, E.G., Seitz, H.K., Cocarcinogenic effects of alcohol in hepatocarcinogenesis (2002) Gut, 51, pp. 132-139Croager, E.J., Smith, P.G.J., Yeoh, G.C.T., Ethanol interactions with a choline-deficient, ethionine-supplemented feeding regime potentiate pre-neoplastic cellular alterations in rat liver (2002) Carcinogenesis, 23, pp. 1685-1693Wanibuchi, H., Wei, M., Karim, R., Existence of no hepatocarcinogenic effect levels of 2-amino-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol (2006) Toxicol Pathol, 34, pp. 232-236Yanagi, S., Yamashita, M., Hiasa, Y., Kamiya, T., Effect of ethanol on hepatocarcinogenesis initiated in rats with 3′-methyl-4-dimethylaminoazobenzene in the absence of liver injuries (1989) Int J Cancer, 44, pp. 681-684Cho, K.J., Jang, J.J., Effects of carbon tetrachloride, ethanol, and acetaldehyde on diethylnitrosamine-induced hepatocarcinogenesis in rats (1993) Cancer Lett, 70, pp. 33-39Holmberg, B., Ekstrom, T., The effects of long-term oral administration of ethanol on Sprague-Dawley rats - A condensed report (1995) Toxicology, 96, pp. 133-145Solt, D., Farber, E., New principles for the analysis of chemical carcinogenesis (1976) Nature, 263, pp. 701-703Semple-Roberts, E., Hayes, M.A., Armstrong, D., Becker, R.A., Racz, W.J., Farber, E., Alternative methods of selecting hepatocellular nodules resistant to 2-acetylaminefluorene (1987) Int J Cancer, 40, pp. 643-645Tatematsu, M., Nagamine, Y., Farber, E., Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver (1983) Cancer Res, 43, pp. 5049-5058Wood, G.A., Sarma, D.S.R., Archer, M.C., Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats (1999) Carcinogenesis, 20, pp. 1169-1175Bannasch, P., Zerban, H., Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response (1992) Mechanism of Carcinogenesis in Risk Identification, pp. 389-427. , In: Vainio H, Magee PN, McGregor DB, McMichal AJ, eds. Lyon: IARC. Sci Publications, no. 116Pinheiro, F., Faria, R.R., de Camargo, J.L., Spinardi-Barbisan, A.L., da Eira, E.F., Barbisan, L.F., Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat (2003) Food Chem Toxicol, 41, pp. 1543-1550Schulte-Hermann, R., Kraupp-Grasl, B., Bursch, W., Gerbracht, U., Timmermann-Trosiener, I., Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver (1989) Toxicol Pathol, 17, pp. 642-649Levin, S., Bucci, T.J., Cohen, S.M., The nomenclature of cell death: Recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists (1999) Toxicol Pathol, 27, pp. 484-490Bradford, M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal Biochem, 72, pp. 248-254Bitsch, A., Hadjiolov, N., Klöhn, P.-C., Bergmann, O., Zwwirner-Baier, I., Neumann, H.-G., Dose-response of early effects related to tumor promotion of 2-acetylaminofluorene (2000) Toxicol Sci, 55, pp. 44-51Imai, T., Masui, T., Ichinose, M., Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization (1997) Carcinogenesis, 18, pp. 545-551De Miglio, M.R., Simile, M.M., Muroni, M.R., Phenotypic reversion of rat neoplastic liver nodules is under genetic control (2003) Int J Cancer, 105, pp. 70-75Kaufmann, W.K., Zhang, Y., Kaufmann, D.G., Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms (1992) Carcinogenesis, 13, pp. 1481-1483Tamano, S., Merlino, G.T., Ward, J.M., Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital (1994) Carcinogenesis, 15, pp. 1791-1798Burr, A.W., Toole, K., Mathew, J., Hines, J.E., Chapman, C., Burt, A.D., Transforming growth factor-α expression is altered during experimental hepatocarcinogenesis (1996) J Pathol, 179, pp. 276-282Kitano, M., Wada, J., Ariki, Y., Possible tumour development from double positive foci for TGF-alpha and GST-P observed in early stages on rat hepatocarcinogenesis (2006) Cancer Sci, 97, pp. 478-483Sandgren, E.P., Luetteke, N.C., Qiu, T.H., Palmiter, R.D., Brinster, R.L., Lee, D.C., Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver (1993) Mol Cell Biol, 13, pp. 320-330Thorgeirsson, S.S., Santoni-Rugiu, E., Transgenic mouse models in carcinogenesis: Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis (1996) Br J Clin Pharmacol, 42, pp. 43-52Kato, J., Sato, Y., Inui, N., Ethanol induces transforming-growth factor-α expression in hepatocytes, leading to a stimulation of collagen synthesis by hepatic stellate cells (2003) Alcohol Clin Exp Res, 27, pp. 58S-63SZerban, H., Radig, S., Kopp-Schneider, A., Bannasch, P., Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability (1994) Carcinogenesis, 15, pp. 2467-2473Grasl-Kraupp, B., Ruttkay-Nedecky, B., Müllauer, H., Taper, H., Huber, W., Bursch, W., Schulte-Hermann R Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression (1997) Hepatology, 25, pp. 906-912Tanaka, T., Hirota, Y., Kuriyama, M., Nishiguchi, S., Otani, S., Time course of change in glutathione s-transferase positive foci and ornithine decarboxylase activity after cessation of long-term alcohol administration in rats (2001) Asian Pac J Cancer Prev, 2, pp. 131-134Mazzantini, R.P., de Conti, A., Moreno, F.S., Persistent and remodeling hepatic preneoplastic lesions present differences in cell proliferation and apoptosis, as well as in p53, Bcl-2 and NF-kappaB pathways (2007) J Cell BiochemFoda, H.D., Zucker, S., Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis (2001) Drug Discov Today, 6, pp. 478-482Aye, M.M., Cuiling, M.A., Lin, H., Bower, K.A., Wiggins, R.C., Luo, J., Ethanol-induced in vitro invasion of breast cancer cells. the contribution of MMP-2 by fibroblasts (2004) Int J Cancer, 112, pp. 738-746Ke, Z., Lin, H., Fan, Z., MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2 (2006) Int J Cancer, 119, pp. 8-1

Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer

Low-density lipoprotein (LDL) receptors are overexpressed in most neoplastic cell lines and provide a mechanism for the internalization and concentration of drug-laden nanoemulsions that bind to these receptors. The aim of the present study was to determine whether the administration of standard chemotherapeutic schemes can alter the expression of LDL and LDL receptor-related protein 1 (LRP-1) receptors in breast carcinoma. Fragments of tumoral and normal breast tissue from 16 consecutive volunteer women with breast cancer in stage II or III were obtained from biopsies before the beginning of neoadjuvant chemotherapy and after chemotherapy, from fragments excised during mastectomy. Tissues were analyzed by immunohistochemistry for both receptors. Because complete response to treatment was achieved in 4 patients, only the tumors from 12 were analyzed. Before chemotherapy, there was overexpression of LDL receptor in the tumoral tissue compared to normal breast tissue in 8 of these patients. LRP-1 receptor overexpression was observed in tumors of 4 patients. After chemotherapy, expression of both receptors decreased in the tumors of 6 patients, increased in 4 and was unchanged in 2. Nonetheless, even when chemotherapy reduced receptors expression, the expression was still above normal. The fact that chemotherapy does not impair LDL receptors expression supports the use of drug carrier systems that target neoplastic cells by the LDL receptor endocytic pathway in patients on conventional chemotherapy

The vitamin D decrease in children with obesity is associated with the development of insulin resistance during puberty: The PUBMEP study

Obesity and cardiometabolic risk have been associated with vitamin D levels even in children. The objective of the present study was to evaluate the association between insulin resistance (IR), cardiometabolic risk factors, and vitamin D in children from prepubertal to pubertal stages. A total of 76 children from the PUBMEP study, aged 4–12 years at baseline, were included. Children were evaluated in prepubertal and pubertal stages. Anthropometric measurements and selected cardiometabolic risk biomarkers, such as plasma glucose, blood lipids, insulin, adiponectin, leptin, and blood pressure, and serum 25-hydroxyvitamin D (25(OH)D) were determined. Children were categorized by obesity degree and IR status combined before and after puberty. Paired t-test and multivariate linear regression analyses were conducted. During puberty, the increase in triacylglycerols, insulin, and HOMA-IR and the decrease in QUICKI were significantly associated with the reduction in 25(OH)D (B = -0.274, p = 0.032; B = -0.219, p = 0.019; B = -0.250, p = 0.013; B = 1.574, p = 0.013, respectively) after adjustment by BMI-z, sex, and pubertal stage. Otherwise, prepubertal non-IR children with overweight/obesity that became IR during puberty showed a significant decrease in 25(OH)D and HDL-c, and an increase in waist circumference and triacylglycerol concentrations (p < 0.05 for all) over time. These results suggest that changes in IR seem to be associated with an effect on 25(OH)D levels during puberty, especially in children with overweight. © 2021 by the authors. Licensee MDPI, Basel, Switzerland

The Landau Pole and Z′Z^{\prime} decays in the 331 bilepton model

We calculate the decay widths and branching ratios of the extra neutral boson $Z^{\prime}$ predicted by the 331 bilepton model in the framework of two different particle contents. These calculations are performed taken into account oblique radiative corrections, and Flavor Changing Neutral Currents (FCNC) under the ansatz of Matsuda as a texture for the quark mass matrices. Contributions of the order of $10^{-1}-10^{-2}$ are obtained in the branching ratios, and partial widths about one order of magnitude bigger in relation with other non- and bilepton models are also obtained. A Landau-like pole arise at 3.5 TeV considering the full particle content of the minimal model (MM), where the exotic sector is considered as a degenerated spectrum at 3 TeV scale. The Landau pole problem can be avoid at the TeV scales if a new leptonic content running below the threshold at $$ TeV is implemented as suggested by other authors.Comment: 20 pages, 5 figures, LaTeX2

The yield of head CT in syncope: a pilot study

Although head CT is often routinely performed in emergency department (ED) patients with syncope, few studies have assessed its value